Holen Sie sich die Stockscreener-App
58.14
9.35%
-6.00
Handel nachbörslich:
57.32
-0.82
-1.41%
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline - Yahoo Finance
How Tarsus Pharmaceuticals Inc. (TARS) Affects Rotational Strategy Timing - Stock Traders Daily
Tarsus Pharmaceuticals Acquires iRenix Medical, Developer of Late-Stage Ocular Antiseptic IRX-101 - VisionMonday.com
All you need to know about Tarsus Pharmaceuticals (TARS) rating upgrade to buy - MSN
Tarsus Pharmaceuticals Acquires iRenix for $75M - Orange County Business Journal
TARS Reiterated by HC Wainwright & Co. -- Price Target Maintained at $88 - GuruFocus
Tarsus Pharmaceuticals (TARS) Q3 2024 earnings summary - Quartr
Tarsus Pharmaceuticals, Inc. (TARS) iRenix Medical, Inc.,M&A CallSlideshow (NASDAQ:TARS) 2026-07-09 - Seeking Alpha
Tarsus Pharmaceuticals (TARS) M&A announcement Summary - Quartr
Tarsus Pharmaceuticals (TARS) Acquires iRenix Medical for $75M - GuruFocus
Tarsus Pharmaceuticals acquires iRenix for $75 million upfront - Investing.com
Tarsus buys iRenix Medical for $75M, gains late-stage eye care asset IRX-101 - MSN
TARS Acquires iRenix Medical for $75M in a Strategic Move - GuruFocus
Tarsus Pharmaceuticals Acquires iRenix With $37.5M Cash, Stock; Milestones Up to $490M - TradingView
Tarsus (NASDAQ: TARS) acquires iRenix, adds late-stage IRX-101 eye asset - Stock Titan
Press Release: Tarsus Advances Eye Care Leadership Strategy With Acquisition of IRenix Medical and Late-Stage Asset IRX-101 - Moomoo
All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy - Yahoo! Finance Canada
Tarsus Pharmaceuticals (TARS) Holds Steady Near Midpoint: Support and Resistance in FocusGap and Reverse - dars.gov.et
Mizuho Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $100 - Moomoo
Tarsus Pharmaceuticals (TARS) moves 7.5% higher: Will this strength last? - MSN
Enterprise value to revenue forward of Tarsus Pharmaceuticals, Inc. – NASDAQ:TARS - TradingView
Price to earnings forward of Tarsus Pharmaceuticals, Inc. – NASDAQ:TARS - TradingView
Price to sales forward of Tarsus Pharmaceuticals, Inc. – NASDAQ:TARS - TradingView
Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last? - Yahoo Finance
Did Copay Allegations and New Director Equity Awards Just Shift Tarsus Pharmaceuticals' (TARS) Investment Narrative? - Sahm
TARSTarsus Pharmaceuticals Inc Short Interest - Finviz
Tarsus Pharmaceuticals stock jumps as investors revisit XDEMVY growth outlook - Quiver Quantitative
Tarsus Pharmaceuticals falls amid Culper Research short call - MSN
Tarsus Pharmaceuticals Faces Medicare Copay Allegations From Culper Research; Shares Fall - Moomoo
TARS Stock Drops After Culper Research Accuses Tarsus Of Illegal Medicare Copay Scheme - Yahoo Finance
Tarsus Pharmaceuticals Stock Drops as Short Seller Alleges Illegal Copay Scheme - Benzinga
TARS: Concerns Raised Over Tarsus Pharmaceuticals' Business Prac - GuruFocus
Culper Research Says We Are Short Tarsus Pharmaceuticals - TradingView
Form 4 Tarsus Pharmaceuticals Inc For: 29 June By Investing.com - Investing.com South Africa
Tarsus (TARS) director awarded RSUs and options for 6,254 shares - Stock Titan
Tarsus Pharmaceuticals (TARS) director receives RSU and stock option grants - Stock Titan
Tarsus Pharmaceuticals (TARS) grants director RSUs and stock options - Stock Titan
Equity awards grant Tarsus (TARS) director RSUs and stock options - Stock Titan
Tarsus (TARS) director receives new RSU and stock option awards - Stock Titan
Tarsus (TARS) director Wendy Yarno receives RSU and option grants as board pay - Stock Titan
Tarsus (TARS) director William J. Link granted options and RSUs - Stock Titan
Tarsus (NASDAQ: TARS) holders back board, pay and auditor - Stock Titan
(TARS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tarsus Pharmaceuticals Inc (TARS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tarsus Pharmaceuticals Inc (TARS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Tarsus Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:TARS) - TradingView
TARS Forecast — Price Target — Prediction for 2027 - TradingView
Tarsus (TARS) CEO Azamian sells 10,000 shares via 10b5-1 trading plan - Stock Titan
Tarsus: Not Cheap, But Xdemvy Makes The Valuation Work - Seeking Alpha
Tarsus Pharmaceuticals director sells $183,384 in company stock By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals director sells $183,384 in company stock - Investing.com UK
Tarsus Pharmaceuticals CFO sells $877k in company shares By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals CFO sells $877k in company shares - Investing.com UK
Tarsus Pharmaceuticals director sells $776,495 in company stock By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals director sells $776,495 in company stock - Investing.com
Tarsus: Not Cheap, But XDEMVY Makes The Valuation Work (NASDAQ:TARS) - Seeking Alpha
Responsive Playbooks and the TARS Inflection - Stock Traders Daily
Tarsus Pharmaceuticals Inc (TARS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Insider Sell Alert: Katherine Goodrich Sells Shares of Tarsus Ph - GuruFocus
Tarsus Pharmaceuticals Inc (TARS) Institutional Confidence - TradingKey
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):